IP Library Granted Patent US 8,722,406
Granted Patent B2
US 8,722,406 · App. 13/198,476 · Granted May 13, 2014

Medium for the protein-free and serum-free cultivation of cells

Inventors: Manfred Reiter (Vienna, AT); Wolfgang Mundt (Vienna, AT); Friedrich Dorner (Vienna, AT); Leopold Grillberger (Vienna, AT); Artur Mitterer (Orth/Donau, AT)
Assignee: Baxter Innovations GmbH
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,722,406
App. No.
13/198,476
Granted
May 13, 2014
Kind
B2
Abstract

A medium is described for the protein-free and serum-free cultivation of cells, especially mammalian cells, whereby the medium contains a proportion of soy hydrolysate.

Claims (19)

1. An animal protein-free and serum-free medium for the cultivation of mammalian cells comprising 0.5-50 g/L soy hydrolysate, wherein at least 40% of said soy hydrolysate has a molecular weight of ≦500 daltons; 1 to 100 g/L synthetic minimal medium; 0.05-1 g/L glutamine; 0.0005-0.05 g/L ascorbic acid; 0.1-10 g/L NaCO 1 ; 0.0005-0.05 g/L ethanolamine; and 1-15 μg/L sodium selenite.

2. An animal protein-free and serum-free medium in accordance with claim 1 wherein said medium contains a quantity in excess of 10 wt % soy hydrolysate based on the total dry weight of the medium.

3. An animal protein-free and serum-free medium in accordance with claim 1 , wherein said medium contains ultrafiltered soy hydrolysate.

4. An animal protein-free and serum-free medium in accordance with claim 1 , wherein the soy hydrolysate has an endotoxin content of <500 U/g.

5. An animal protein-free and serum-free medium in accordance with claim 1 , wherein at least 50% of the soy hydrolysate has a molecular weight of ≦500 daltons.

6. An animal protein-free and serum-free medium in accordance with claim 5 , wherein at least 55% of the soy hydrolysate has a molecular weight of ≦500 daltons.

7. An animal protein-free and serum-free medium in accordance with claim 1 , wherein said medium also contains an additional amino acid.

8. An animal protein-free and serum-free medium in accordance with claim 7 , wherein said additional amino acid is selected from the group consisting of L-asparagine, L-cysteine, L-cystine, L-proline, L-tryptophan, L-glutamine and mixtures thereof.

9. An animal protein-free and serum-free medium in accordance with claim 1 wherein said medium also contains auxiliary substances selected from the group consisting of buffer substances, oxidation stabilizers, stabilizers to counteract mechanical stress, and protease inhibitors.

10. An animal protein-free and serum-free medium in accordance with claim 1 , wherein the synthetic minimal medium is DMEM/HAM'S F12.

11. An animal protein-free and serum-free medium in accordance with claim 1 , wherein the medium further comprises 0.01-10 g/L non-ionic surfactant.

12. A cell culture composition comprising mammalian cells and an animal protein-free and serum-free medium in accordance with claim 1 .

13. A process for the cultivation of mammalian cells, comprising introducing said cells into an animal protein-free and serum-free medium in accordance with claim 1 and growing said cells in said medium.

14. The process of claim 13 , wherein the mammalian cells are selected from the group consisting of CHO cells and BHK cells.

15. A process for the production of a protein from cell culture comprising:

introducing mammalian cells into an animal protein-free and serum-free medium in accordance with claim 1 , wherein said cells express a desired protein;

growing said cells in said medium and expressing said protein, thereby producing a mixture of said cells and said protein in the medium; and

purifying said protein from said mixture.

16. The process of claim 15 , wherein the mammalian cells produce a recombinant protein selected from the group consisting of Factor II, Factor V, Factor VII, Factor VIII, Factor IX, Factor X, Factor XI, Protein S, Protein C, activated forms of these factors, and vWF.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2017
From: BAXALTA INNOVATIONS GMBH
To: BAXALTA INCORPORATED; BAXALTA GMBH
Reel/Frame 042084/0971 →
CHANGE OF NAME Recorded Aug 9, 2016
From: BAXTER INNOVATIONS GMBH
To: BAXALTA INNOVATIONS GMBH
Reel/Frame 039635/0375 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 8, 2011
From: REITER, MANFRED; MUNDT, WOLFGANG; DORNER, FRIEDRICH; GRILLBERGER, LEOPOLD; MITTERER, ARTUR
To: BAXTER INNOVATIONS GMBH
Reel/Frame 026716/0392 →
Priority Claims (1)
AT A 1659/99 · Sep 28, 1999 · national
Continuity (4)
Continuation 11844915 · Aug 20, 2007
Continuation 10405794 · Apr 1, 2003
Continuation 09672240 · Sep 28, 2000
Related Publication 20110287482A1 · Nov 24, 2011